UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055738
Receipt number R000063670
Scientific Title Effects of food intake on cerebral blood flow and concentration during tasks
Date of disclosure of the study information 2024/10/07
Last modified on 2025/04/10 08:45:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of food intake on cerebral blood flow and concentration during tasks

Acronym

Effects of food intake on cerebral blood flow and concentration during tasks

Scientific Title

Effects of food intake on cerebral blood flow and concentration during tasks

Scientific Title:Acronym

Effects of food intake on cerebral blood flow and concentration during tasks

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of food intake on cerebral blood flow and concentration during tasks

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

*Cerebral blood flow: hemoglobin concentration (OXHb, DXHb, TOHb)
*Number of correct answers to the Stroop task
*Solution speed
*Subjective symptoms (VAS)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food

Interventions/Control_1

Test food

Interventions/Control_2

No intake

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Those who can eat the test foods ( preference)
(2) Those who are not averse to pungent fragrances
(3) Those who have received sufficient explanation of the purpose and content of the study, have the ability to consent, have voluntarily volunteered to participate with a good understanding, and have agreed to participate in this study in writing

Key exclusion criteria

(1) Those who have any symptoms that may affect test food intake
(2) Those currently undergoing dental treatment, including orthodontic treatment (except for periodic cleanings).
(3) Those who may develop allergies related to the study
(4) Those who are judged by the study representative to be inappropriate to participate in this study
(5) Those taking medications that are thought to have the potential to affect the results
(6) Those who are pregnant or lactating
(7) Those who are otherwise deemed unsuitable as subjects by the test administrator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Research and Development Center, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Email

okabayashi_kazuto@lotte.co.jp


Public contact

Name of contact person

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Research and Development Center, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Homepage URL


Email

okabayashi_kazuto@lotte.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic

Address

6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 09 Month 24 Day

Date of IRB

2024 Year 09 Month 26 Day

Anticipated trial start date

2024 Year 10 Month 07 Day

Last follow-up date

2024 Year 12 Month 10 Day

Date of closure to data entry

2024 Year 12 Month 10 Day

Date trial data considered complete

2024 Year 12 Month 19 Day

Date analysis concluded

2025 Year 02 Month 05 Day


Other

Other related information



Management information

Registered date

2024 Year 10 Month 04 Day

Last modified on

2025 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063670